Author:
Gao Wei,Li Na,Cui Xiao-guang
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Complementary and alternative medicine,General Medicine
Reference31 articles.
1. Morariu AM, Loef BG, Aarts LP, Rietman GW, Rakhorst G, van Oevere W, et al. Dexamethasone: benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting: a study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest 2005;128:2677–2687.
2. Apostolakis E, Filos KS, Koletsis E, Dougenis D. Lung dysfunction following cardiopulmonary bypass. J Card Surg 2010;25:47–55.
3. Xing Z, Han J, Hao X, Wang J, Jiang C, Hao Y, et al. Immature monocytes contribute to cardiopulmonary bypassinduced acute lung injury by generating inflammatory descendants. Thorax 2017;72:245–255.
4. He XD, Wang Y, Wu Q, Wang HX, Chen ZD, Zheng RS, et al. Xuebijing protects rats from sepsis challenged with acinetobacter baumannii by promoting annexin α1 expression and inhibiting proinflammatory cytokines secretion. Evid Based Complement Alternat Med 2013;2013:804940.
5. Sun J, Xue Q, Guo L, Cui L, Wang J. Xuebijing protects against lipopolysaccharide-induced lung injury in rabbits. Exp Lung Res 2010;36:211–218.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献